News

European venture capitalists are no longer prepared to take any risk with their investments, undermining the biotech sector. That, anyway, is the opinion of many a frustrated biotech entrepreneur.

European companies are set to increase their investment in R&D by 5 per cent per annum over the next three years, closing the gap with US counterparts.

Europe came a step closer to ensuring its future competitiveness last week when member states endorsed a programme of sustainable chemistry.

A pay-per-vote Web site offers a new way to fund science, one dollar at a time.

Male scientists are more likely to file patents on their research than their female colleagues.

A driving force in the growing demand for MEMS could be pressure to make cars safer.

It may be that the similarity between the name of a US memory chip supplier, Rambus, and that of a rebel and indomitable hero, Rambo, is purely coincidental. Yet, looking at the story of Rambus, it is difficult to avoid comparisons.